Published in

Taylor and Francis Group, Expert Opinion on Investigational Drugs, 6(31), p. 567-591, 2022

DOI: 10.1080/13543784.2022.2049232

Links

Tools

Export citation

Search in Google Scholar

Progress and pitfalls in the use of immunotherapy for patients with triple negative breast cancer

Journal article published in 2022 by Elisa Agostinetto ORCID, Agnese Losurdo, Guilherme Nader-Marta ORCID, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok ORCID, Evandro de Azambuja ORCID, Matteo Lambertini ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO